Health development and scientific reasearch in the capital
Conditions
Interventions
Group1:Taking Jinghuaweikang capsule analog for 28 days
Group2:Taking Jinghuaweikang capsule for 28 days
Sponsors
Peking Univeisity First Hospital
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >= 65 years, genders are unlimited; 2. HP infection was diagnosed by urea 13C breath test, endoscopic rapid urease test or stool antigen test; 3. Except for gastrointestinal tumor and other space occupying lesions through endoscope or abdominal CT, gastrointestinal ultrasound, gastrointestinal contrast radiography and other imaging test; 4. There are more than two chronic diseases such as diabetes, dyslipidemia, cardiovascular and cerebrovascular diseases, hypertension, thyroid dysfunction, COPD, immune system diseases, or two or more drugs taken orally for a long time ( >= 3 months); 5. No antibiotics within 1 month, no acid inhibitors or or bismuth agent within 2 weeks; 6. The subjects (or legal representatives) voluntarily consented and signed informed consent and were able to follow the research program during the study.
Exclusion criteria
Exclusion criteria: 1. Having a history of gastric surgery; 2. Having active gastrointestinal bleeding and peptic ulcer; 3. With serious diseases affecting the evaluation of the study, such as serious liver disease, heart disease, kidney disease, malignant tumor and alcoholism; 4. Allergic to the drugs applied in the study; 5. With low lung function; 6. Having participated in other drug clinical studies within 3 months before participating in this project; 7. Patients could not express their subjective feelings correctly and could not cooperate with each other.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of symptoms;Breath; | — |
Countries
China
Contacts
Public ContactHui Ye
Outcome results
None listed